News
Medtronic spins off
Medtronic has announced plans to separate out its diabetes business into a new standalone company.
Medtronic has announced plans to separate out its diabetes business into a new standalone company. The separation will serve to create an “independent, scaled leader in diabetes” that boasts an ecosystem of insulin management devices including pumps and continuous glucose monitors.The split will also in turn create a wholly “more focused” Medtronic, with a more simplified portfolio in high margin growth markets.
Type: industry
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
